| dc.contributor.author | Islek I. | |
| dc.contributor.author | Baris S. | |
| dc.contributor.author | Katranci A.O. | |
| dc.contributor.author | Ariturk E. | |
| dc.contributor.author | Gurses N. | |
| dc.date.accessioned | 2020-06-21T09:14:45Z | |
| dc.date.available | 2020-06-21T09:14:45Z | |
| dc.date.issued | 2003 | |
| dc.identifier.issn | 1476-0711 | |
| dc.identifier.uri | https://doi.org/10.1186/1476-0711-2-1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/2503 | |
| dc.description.abstract | Background: Cefoperazone has not been reported to cause vasculitic complications before. Here, we report a case of hypersensitivity vasculitis associated with cefoperazone/sulbactam. Case presentation: A 13-year-old girl with appendicitis developed hypersensitivity vasculitis on the fifth day of cefoperazone/sulbactam therapy. Hypersensitivity vasculitis resolved gradually after removal of the agent on the seventh day and did not recur. Although hypersensitivity vasculitis has multiple causes, coexistence of hypersensitivity vasculitis and cefoperazone treatment, and the quite resolution of the disease after removal of the drug, strongly favours a causative relationship. Conclusion: To our knowledge, this is the first report of a hypersensitivity vasculitis associated with cefoperazone. © 2003 Islek et al; licensee BioMed Central Ltd. | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.1186/1476-0711-2-1 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Cefoperazone | en_US |
| dc.subject | Hypersensitivity vasculitis | en_US |
| dc.title | Hypersensitivity vasculitis induced by cefoperazone/sulbactam | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 2 | en_US |
| dc.relation.journal | Annals of Clinical Microbiology and Antimicrobials | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
